Skip to content

Limited-English Proficiency (LEP) Virtual Reality (VR) Study

Addressing Parental and Pediatric Anxiety Through Virtual Reality (VR) Intervention in (Limited-English Proficiency) LEP Populations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03689868
Enrollment
44
Registered
2018-10-01
Start date
2018-08-24
Completion date
2021-07-09
Last updated
2023-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Language, Parents

Keywords

virtual reality

Brief summary

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety in parental and pediatric populations with limited English proficiency (LEP).

Interventions

BEHAVIORALVirtual Reality

Virtual Reality headset with calming scenery

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 0-99 (Child participants will be ages 0 to 17. Parents of children of any age may also be enrolled) * Able to consent * Self-identified as having a limited English proficiency or English-proficiency

Exclusion criteria

* People who do not consent * Significant Cognitive Impairment * History of Severe Motion Sickness * Current Nausea * Seizures * Visual Problems * Patients whose children are clinically unstable or require urgent/emergent intervention

Design outcomes

Primary

MeasureTime frameDescription
Procedural-Related AnxietyDuration of intervention, approximately 20-30 minutesValidated questionnaires regarding anxiety will be administers pre- and post-intervention (i.e virtual reality) and compared to those in the control arm (i.e no virtual reality)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026